Alpha-mannosidosis
📧 Sign up to get email alerts when something new happens for Alpha-mannosidosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-02EMA Authorised: Lamzede (velmanase alfa) — Chiesi Farmaceutici S.p.A.
The European Medicines Agency authorised Lamzede (velmanase alfa) by Chiesi Farmaceutici S.p.A. for the treatment of alpha-mannosidosis, wit…
-
FDA approval · 2023-02-16FDA Approved: LAMZEDE — Original Application (Chiesi USA, Inc.)
FDA approved Lamzede (velmanase alfa-tycv) from Chiesi USA as an original Biologics License Application for the treatment of alpha-mannosido…
-
EMA approval · 2018-01-26New enzyme replacement therapy to treat rare genetic disorder alpha-mannosidosis in children and adults
EMA announces approval of a new enzyme replacement therapy for alpha-mannosidosis, a rare genetic disorder, for use in children and adults.